Northern Trust
CMTA

Northern Trust’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Northern Trust’s Portfolio CMTA Stock Details CMTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-16,211
Closed -$191K – 4276
2018
Q4 		$191K Buy
16,211
+2,335
+17% +$29K ﹤0.01% 3807
2018
Q3 		$155K Buy
13,876
+1,633
+13% +$17.2K ﹤0.01% 3925
2018
Q2 		$161K Buy
12,243
+1,679
+16% +$27.2K ﹤0.01% 3912
2018
Q1 		$160K Sell
10,564
-229
-2% -$3.73K ﹤0.01% 3875
2017
Q4 		$205K Buy
+10,793
New +$181K ﹤0.01% 3812

Other funds holding CMTA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
KLCMU
Kite Lake Capital Management (UK) London, United Kingdom $125M AUM 198.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Northern Trust's CMTA Position: Q1 2019 in Review

Northern Trust sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q1 2019, closing a stake of 16,211 shares — an estimated $191K sold.

Northern Trust first reported a position in CMTA in Q4 2017 and held it in 5 quarters. The position peaked at $205K in Q4 2017. 48 funds tracked by Wall St. Rank hold CMTA as of Q1 2019.

  • Northern Trust reported no remaining Clementia Pharmaceuticals Inc. position as of Q1 2019 after selling out during the quarter.
  • Northern Trust sold 16,211 Clementia Pharmaceuticals Inc. shares in Q1 2019, an estimated $191K.
  • Northern Trust first reported a position in Clementia Pharmaceuticals Inc. in Q4 2017 and held it in 5 quarters.
  • Northern Trust's Clementia Pharmaceuticals Inc. position peaked at $205K in Q4 2017.
  • 48 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q1 2019.

Based on Northern Trust's 13F filing for Q1 2019, filed 13 May 2019.